Sieun Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sieun Choi has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Seok Chung
KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea
3 shared publications Dain Lee
KU-KIST Graduate School of Converging Science and Technology, Korea Univresity
2 shared publications- Jinchul Ahn
School of Mechanical Engineering, Korea University, Seoul, Republic of Korea
2 shared publications - Minseop Kim
KU‐KIST Graduate School of Converging Science and Technology Korea University Seoul Republic of Korea
2 shared publications Bukyung Cha
Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea
1 shared publication- Dong-Hee Choi
School of Mechanical Engineering, Korea University, Seoul, South Korea
1 shared publication
Latest Publications
- Open Access
- 26 May 2025
- Published by Springer Nature in Research Square
TRAF6-Mediated Ubiquitin Signaling Drives Long-Term Neurodegeneration in a Mouse Model of Chronic Traumatic Encephalopathy
Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease leading to cerebral complications. It is triggered by single or repetitive traumatic brain injury during contact sports or combat activities. Due to diagnostic limitations, i.e., being restricted to postmortem analysis, understanding of CTE remains incomplete. While acute CTE mechanisms have been studied, the long-term effects remain inadequately explored. We investigated long-term CTE mechanisms using mouse models with 3- and 6-month progression. The 6-month model showed increased neurodegeneration and upregulation of ubiquitin signaling pathway genes, identifying TRAF6 as the central node. Accordingly, TRAF6 suppression using AAV9-delivered shRNA after brain injury protected against damage and behavioral deficits. However, TRAF6 knockdown in uninjured animals induced CTE-like changes, suggesting trauma activates compensatory mechanisms. Circulating microRNAs from blood serum reflect these brain changes, offering potential for non-invasive diagnostic approaches. Our findings indicate TRAF6 mediated signaling regulate long-term CTE pathology and present targets for therapeutic development.
- 26 May 2025
- Published by Springer Nature in Research Square
Open AccessTRAF6-Mediated Ubiquitin Signaling Drives Long-Term Neurodegeneration in a Mouse Model of Chronic Traumatic Encephalopathy
Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease leading to cerebral complications. It is triggered by single or repetitive traumatic brain injury during contact sports or combat activities. Due to diagnostic limitations, i.e., being restricted to postmortem analysis, understanding of CTE remains incomplete. While acute CTE mechanisms have been studied, the long-term effects remain inadequately explored. We investigated long-term CTE mechanisms using mouse models with 3- and 6-month progression. The 6-month model showed increased neurodegeneration and upregulation of ubiquitin signaling pathway genes, identifying TRAF6 as the central node. Accordingly, TRAF6 suppression using AAV9-delivered shRNA after brain injury protected against damage and behavioral deficits. However, TRAF6 knockdown in uninjured animals induced CTE-like changes, suggesting trauma activates compensatory mechanisms. Circulating microRNAs from blood serum reflect these brain changes, offering potential for non-invasive diagnostic approaches. Our findings indicate TRAF6 mediated signaling regulate long-term CTE pathology and present targets for therapeutic development.
- 22 October 2024
- Published by Springer Nature in Nature Methods
- Vol. 21 (11) , 2135-2146
Differentiating visceral sensory ganglion organoids from induced pluripotent stem cells
The ability to generate visceral sensory neurons (VSN) from induced pluripotent stem (iPS) cells may help to gain insights into how the gut–nerve–brain axis is involved in neurological disorders. We established a protocol to differentiate human iPS-cell-derived visceral sensory ganglion organoids (VSGOs). VSGOs exhibit canonical VSN markers, and single-cell RNA sequencing revealed heterogenous molecular signatures and developmental trajectories of VSGOs aligned with native VSN. We integrated VSGOs with human colon organoids on a microfluidic device and applied this axis-on-a-chip model to Alzheimer’s disease. Our results suggest that VSN could be a potential mediator for propagating gut-derived amyloid and tau to the brain in an APOE4- and LRP1-dependent manner. Furthermore, our approach was extended to include patient-derived iPS cells, which demonstrated a strong correlation with clinical data.
- 22 October 2024
- Published by Springer Nature in Nature Methods
- Vol. 21 (11) , 2135-2146
Differentiating visceral sensory ganglion organoids from induced pluripotent stem cells
The ability to generate visceral sensory neurons (VSN) from induced pluripotent stem (iPS) cells may help to gain insights into how the gut–nerve–brain axis is involved in neurological disorders. We established a protocol to differentiate human iPS-cell-derived visceral sensory ganglion organoids (VSGOs). VSGOs exhibit canonical VSN markers, and single-cell RNA sequencing revealed heterogenous molecular signatures and developmental trajectories of VSGOs aligned with native VSN. We integrated VSGOs with human colon organoids on a microfluidic device and applied this axis-on-a-chip model to Alzheimer’s disease. Our results suggest that VSN could be a potential mediator for propagating gut-derived amyloid and tau to the brain in an APOE4- and LRP1-dependent manner. Furthermore, our approach was extended to include patient-derived iPS cells, which demonstrated a strong correlation with clinical data.
- Open Access
- 2 February 2024
- Published by Springer Nature in NPG Asia Materials
- Vol. 16 (1) , 1-12
An advanced 3D lymphatic system for assaying human cutaneous lymphangiogenesis in a microfluidic platform
The human cutaneous lymphatic system strictly controls lymphatic functions by coordinating with skin cells. The lymphatic system plays important roles in removing cell waste, residual proteins, various antigens, and immune cells from tissues to maintain homeostasis and activate the immune system through the drainage of interstitial fluid1,2. The skin protects our body from external stimuli such as pathogens through the cutaneous lymphatic system3,4. Herein, to develop an in vitro human cutaneous lymphatic model, we present two 3D microfluidic platforms: a lymphangiogenesis model with a precollecting lymphatic vessel-like structure and an advanced lymphangiogenesis model with a functional cutaneous barrier and a precollecting lymphatic vessel-like structure. In addition, we rapidly analyzed prolymphangiogenic effects using methods that incorporate a high-speed image processing system and a deep learning-based vascular network analysis algorithm by 12 indices. Using these platforms, we evaluated the pro-lymphangiogenic effect of Lymphanax, a natural product derived from fresh ginseng. As a result, we demonstrated that Lymphanax induces robust lymphangiogenesis without any structural abnormalities. In conclusion, we suggest that these innovative platforms are useful for studying the interaction between the skin and lymphatic system as well as evaluating the prolymphangiogenic effects of drugs and cosmetics.
- 2 February 2024
- Published by Springer Nature in NPG Asia Materials
- Vol. 16 (1) , 1-12
Open AccessAn advanced 3D lymphatic system for assaying human cutaneous lymphangiogenesis in a microfluidic platform
The human cutaneous lymphatic system strictly controls lymphatic functions by coordinating with skin cells. The lymphatic system plays important roles in removing cell waste, residual proteins, various antigens, and immune cells from tissues to maintain homeostasis and activate the immune system through the drainage of interstitial fluid1,2. The skin protects our body from external stimuli such as pathogens through the cutaneous lymphatic system3,4. Herein, to develop an in vitro human cutaneous lymphatic model, we present two 3D microfluidic platforms: a lymphangiogenesis model with a precollecting lymphatic vessel-like structure and an advanced lymphangiogenesis model with a functional cutaneous barrier and a precollecting lymphatic vessel-like structure. In addition, we rapidly analyzed prolymphangiogenic effects using methods that incorporate a high-speed image processing system and a deep learning-based vascular network analysis algorithm by 12 indices. Using these platforms, we evaluated the pro-lymphangiogenic effect of Lymphanax, a natural product derived from fresh ginseng. As a result, we demonstrated that Lymphanax induces robust lymphangiogenesis without any structural abnormalities. In conclusion, we suggest that these innovative platforms are useful for studying the interaction between the skin and lymphatic system as well as evaluating the prolymphangiogenic effects of drugs and cosmetics.